Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 48


Mapping the Relationship of Contributing Factors for Preclinical Alzheimer's Disease.

Shi L, Zhao L, Wong A, Wang D, Mok V.

Sci Rep. 2015 Jul 20;5:11259. doi: 10.1038/srep11259.


Absence of practice effects in preclinical Alzheimer's disease.

Hassenstab J, Ruvolo D, Jasielec M, Xiong C, Grant E, Morris JC.

Neuropsychology. 2015 Nov;29(6):940-8. doi: 10.1037/neu0000208. Epub 2015 May 25.


Vascular imaging abnormalities and cognition: mediation by cortical volume in nondemented individuals: atherosclerosis risk in communities-neurocognitive study.

Knopman DS, Griswold ME, Lirette ST, Gottesman RF, Kantarci K, Sharrett AR, Jack CR Jr, Graff-Radford J, Schneider AL, Windham BG, Coker LH, Albert MS, Mosley TH Jr; ARIC Neurocognitive Investigators.

Stroke. 2015 Feb;46(2):433-40. doi: 10.1161/STROKEAHA.114.007847. Epub 2015 Jan 6.


Integrated cortical structural marker for Alzheimer's disease.

Ming J, Harms MP, Morris JC, Beg MF, Wang L.

Neurobiol Aging. 2015 Jan;36 Suppl 1:S53-9. doi: 10.1016/j.neurobiolaging.2014.03.042. Epub 2014 Oct 12.


Imaging biomarkers associated with cognitive decline: a review.

McConathy J, Sheline YI.

Biol Psychiatry. 2015 Apr 15;77(8):685-92. doi: 10.1016/j.biopsych.2014.08.024. Epub 2014 Sep 16. Review.


A review of neuroimaging biomarkers of Alzheimer's disease.

Varghese T, Sheelakumari R, James JS, Mathuranath P.

Neurol Asia. 2013;18(3):239-248.


Participation in cognitively-stimulating activities is associated with brain structure and cognitive function in preclinical Alzheimer's disease.

Schultz SA, Larson J, Oh J, Koscik R, Dowling MN, Gallagher CL, Carlsson CM, Rowley HA, Bendlin BB, Asthana S, Hermann BP, Johnson SC, Sager M, LaRue A, Okonkwo OC.

Brain Imaging Behav. 2015 Dec;9(4):729-36. doi: 10.1007/s11682-014-9329-5.


At the interface of sensory and motor dysfunctions and Alzheimer's disease.

Albers MW, Gilmore GC, Kaye J, Murphy C, Wingfield A, Bennett DA, Boxer AL, Buchman AS, Cruickshanks KJ, Devanand DP, Duffy CJ, Gall CM, Gates GA, Granholm AC, Hensch T, Holtzer R, Hyman BT, Lin FR, McKee AC, Morris JC, Petersen RC, Silbert LC, Struble RG, Trojanowski JQ, Verghese J, Wilson DA, Xu S, Zhang LI.

Alzheimers Dement. 2015 Jan;11(1):70-98. doi: 10.1016/j.jalz.2014.04.514. Epub 2014 Jul 9. Review.


Vascular risk and Aβ interact to reduce cortical thickness in AD vulnerable brain regions.

Villeneuve S, Reed BR, Madison CM, Wirth M, Marchant NL, Kriger S, Mack WJ, Sanossian N, DeCarli C, Chui HC, Weiner MW, Jagust WJ.

Neurology. 2014 Jul 1;83(1):40-7. doi: 10.1212/WNL.0000000000000550. Epub 2014 Jun 6.


Brain region's relative proximity as marker for Alzheimer's disease based on structural MRI.

Lillemark L, Sørensen L, Pai A, Dam EB, Nielsen M; Alzheimer's Disease Neuroimaging Initiative.

BMC Med Imaging. 2014 Jun 2;14:21. doi: 10.1186/1471-2342-14-21.


MTA index: a simple 2D-method for assessing atrophy of the medial temporal lobe using clinically available neuroimaging.

Menéndez-González M, López-Muñiz A, Vega JA, Salas-Pacheco JM, Arias-Carrión O.

Front Aging Neurosci. 2014 Mar 24;6:23. doi: 10.3389/fnagi.2014.00023. eCollection 2014.


Parahippocampal white matter volume predicts Alzheimer's disease risk in cognitively normal old adults.

Stoub TR, Detoledo-Morrell L, Dickerson BC.

Neurobiol Aging. 2014 Aug;35(8):1855-61. doi: 10.1016/j.neurobiolaging.2014.01.153. Epub 2014 Feb 18.


The thickness of posterior cortical areas is related to executive dysfunction in Alzheimer's disease.

Vasconcelos Lde G, Jackowski AP, Oliveira MO, Flor YM, Souza AA, Bueno OF, Brucki SM.

Clinics (Sao Paulo). 2014 Jan;69(1):28-37. doi: 10.6061/clinics/2014(01)05.


Reduced FDG-PET brain metabolism and executive function predict clinical progression in elderly healthy subjects.

Ewers M, Brendel M, Rizk-Jackson A, Rominger A, Bartenstein P, Schuff N, Weiner MW; Alzheimer's Disease Neuroimaging Initiative (ADNI).

Neuroimage Clin. 2013 Nov 4;4:45-52. doi: 10.1016/j.nicl.2013.10.018. eCollection 2014.


Promising developments in neuropsychological approaches for the detection of preclinical Alzheimer's disease: a selective review.

Rentz DM, Parra Rodriguez MA, Amariglio R, Stern Y, Sperling R, Ferris S.

Alzheimers Res Ther. 2013 Nov 21;5(6):58. doi: 10.1186/alzrt222. eCollection 2013. Review.


Does amyloid deposition produce a specific atrophic signature in cognitively normal subjects?

Whitwell JL, Tosakulwong N, Weigand SD, Senjem ML, Lowe VJ, Gunter JL, Boeve BF, Knopman DS, Dickerson BC, Petersen RC, Jack CR Jr.

Neuroimage Clin. 2013 Jan 24;2:249-57. doi: 10.1016/j.nicl.2013.01.006. eCollection 2013.


Large-scale brain networks of the human left temporal pole: a functional connectivity MRI study.

Pascual B, Masdeu JC, Hollenbeck M, Makris N, Insausti R, Ding SL, Dickerson BC.

Cereb Cortex. 2015 Mar;25(3):680-702. doi: 10.1093/cercor/bht260. Epub 2013 Sep 24.


Gray-matter macrostructure in cognitively healthy older persons: associations with age and cognition.

Fleischman DA, Leurgans S, Arfanakis K, Arvanitakis Z, Barnes LL, Boyle PA, Han SD, Bennett DA.

Brain Struct Funct. 2014 Nov;219(6):2029-49. doi: 10.1007/s00429-013-0622-7. Epub 2013 Aug 17.


Decreased white matter integrity in neuropsychologically defined mild cognitive impairment is independent of cortical thinning.

Stricker NH, Salat DH, Foley JM, Zink TA, Kellison IL, McFarland CP, Grande LJ, McGlinchey RE, Milberg WP, Leritz EC.

J Int Neuropsychol Soc. 2013 Sep;19(8):925-37. doi: 10.1017/S1355617713000660. Epub 2013 Jul 1.


An expanded role for neuroimaging in the evaluation of memory impairment.

Desikan RS, Rafii MS, Brewer JB, Hess CP.

AJNR Am J Neuroradiol. 2013 Nov-Dec;34(11):2075-82. doi: 10.3174/ajnr.A3644. Epub 2013 Jun 13.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk